Finance

Lists
Why is NERV down ४.३५%?
Dive Deeper
NERV:NASDAQ
Minerva Neurosciences, Inc
US$ २.२०
-४.३५%
(-०.१००) 1D
US$ २.२०
०.००% (०.००)
After hours
Closed: नोभेम्बर १६, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NERV...
Open
US$ २.३०
High
US$ २.३२
Low
US$ २.१८
Mkt. cap
१०.९६ करोड
Avg. vol.
१.७५ लाख
Volume
१.४२ लाख
52-wk high
US$ ८.८०
52-wk low
US$ १.९६
EPS
-US$ २८.४६
Beta
-०.६४
Shares outstanding
४.९८ करोड
No. of employees
७
Open
US$ २.३०
High
US$ २.३२
Low
US$ २.१८
Mkt. cap
१०.९६ करोड
Avg. vol.
१.७५ लाख
Volume
१.४२ लाख
52-wk high
US$ ८.८०
52-wk low
US$ १.९६
EPS
-US$ २८.४६
Beta
-०.६४
Shares outstanding
४.९८ करोड
No. of employees
७
News stories
From web sources and news partners
Investing.com
Investing.com
·
२२ मिनेट पहिले
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
24/7 Wall St.
24/7 Wall St.
·
४७ मिनेट पहिले
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
ChartMill
·
१ घण्टा पहिले
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
About Minerva Neurosciences, Inc
CEO-
Employees७
Founded२००७
HeadquartersBurlington, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 1 analyst giving stock ratings to NERV in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NERV in the last 3 months
Highest
Current US$ २.२०
US$ ७.०० (+२१८.१८%)
Average
US$ ७.०० (+२१८.१८%)
Lowest
US$ ७.०० (+२१८.१८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Hold
Maintained
US$ ७.००
+२१८.२%
11/09/2026
Andrew Tsai
Jefferies
Buy
Upgraded
US$ १०.००
+३५४.५%
08/14/2026
Jason Butler
Citizens JMP
Buy
Initiated
US$ १४.००
+५३६.४%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
-
५२.५५ लाख
-५२.५५ लाख
-
Cost of revenue
-
५२.५५ लाख
-५२.५५ लाख
-
Research and development expenses
२१.७४ लाख
-
१.२४ करोड
५१.५६ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२८.०८ लाख
१.१४ करोड
-३१.४५ लाख
४२.७८ लाख
Operating expense
४९.८२ लाख
१.१४ करोड
९२.९७ लाख
९४.३४ लाख
Total operating expenses
४९.८२ लाख
१.६७ करोड
४०.४२ लाख
९४.३४ लाख
Operating income
-४९.८२ लाख
-१.६७ करोड
-४०.४२ लाख
-९४.३४ लाख
Other non operating income
-२७.९२ करोड
-१०.९४ करोड
२.७६ करोड
१०.९६ करोड
EBT including unusual items
-२८.३७ करोड
-१२.५४ करोड
१.७५ करोड
१०.०७ करोड
EBT excluding unusual items
-२८.३७ करोड
-१२.५४ करोड
२.४१ करोड
१०.०७ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२८.३७ करोड
-१२.५४ करोड
१.७५ करोड
१०.०७ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.६४
-०.१७
-०.१७
-
Interest and investment income
५.४७ लाख
६.३० लाख
५.७० लाख
५.८७ लाख
Interest expense
-
-
-
-
Net interest expenses
५.४७ लाख
६.३० लाख
५.७० लाख
५.८७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-४९.८० लाख
-१.६७ करोड
-४०.४१ लाख
-९४.३२ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू